For example, loss of BRG1 and BRM expression has been reported in human NSCLC cell lines [30] both NSCLC and SCLC solid tumors, and this loss has been associated with a poor patient survival, when compared to patients with BRG1/BRM-positive lung tumors. Here, SMARCA2 is linked to small cell lung carcinoma.